Form 8-K - Current report:
SEC Accession No. 0001125345-21-000052
Filing Date
2021-04-02
Accepted
2021-04-01 19:44:17
Documents
15
Period of Report
2021-03-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20210330.htm   iXBRL 8-K 36668
2 EX-3.1 a8-k_bylawxamendmentxexx3x1.htm EX-3.1 147708
  Complete submission text file 0001125345-21-000052.txt   354319

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20210330.xsd EX-101.SCH 2420
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20210330_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20210330_def.xml EX-101.DEF 1641
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20210330_lab.xml EX-101.LAB 24977
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20210330_pre.xml EX-101.PRE 13185
8 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20210330_htm.xml XML 11261
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 21800106
SIC: 2834 Pharmaceutical Preparations